Search Page

1

Cite

Share

[Survival increases for all cancer diagnoses - but inequality persists].

Henriksson R, Järås J, Bergfeldt K, Sharp L, Ridderheim M, Degsell E, Kunze T. Henriksson R, et al. Among authors: ridderheim m. Lakartidningen. 2018 May 8;115:E43P. Lakartidningen. 2018. PMID: 29738056 Free article. Swedish.

Cite

Share

2

Cite

Share

The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.

Johansson B, Ridderheim M, Glimelius B. Johansson B, et al. Among authors: ridderheim m. Acta Oncol. 2005;44(8):890-5. doi: 10.1080/02841860500355942. Acta Oncol. 2005. PMID: 16332598 Review.

Cite

Share

3

Cite

Share

A systematic overview of radiation therapy effects in ovarian cancer.

Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E. Einhorn N, et al. Among authors: ridderheim m. Acta Oncol. 2003;42(5-6):562-6. doi: 10.1080/02841860310014426. Acta Oncol. 2003. PMID: 14596514 Review.

Cite

Share

4

Cite

Share

A systematic overview of radiation therapy effects in cervical cancer (cervix uteri).

Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E. Einhorn N, et al. Among authors: ridderheim m. Acta Oncol. 2003;42(5-6):546-56. doi: 10.1080/02841860310014660. Acta Oncol. 2003. PMID: 14596512 Review.

Cite

Share

5

Cite

Share

A systematic overview of radiation therapy effects in uterine cancer (corpus uteri).

Einhorn N, Tropé C, Ridderheim M, Boman K, Sorbe B, Cavallin-Ståhl E. Einhorn N, et al. Among authors: ridderheim m. Acta Oncol. 2003;42(5-6):557-61. doi: 10.1080/02841860310014417. Acta Oncol. 2003. PMID: 14596513 Review.

Cite

Share

6

Cite

Share

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer.

Poole CJ, Perren T, Gawande S, Ridderheim M, Cook J, Jenkins A, Roychowdhury D. Poole CJ, et al. Among authors: ridderheim m. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):507-14. doi: 10.1111/j.1525-1438.2006.00466.x. Int J Gynecol Cancer. 2006. PMID: 16681719 Clinical Trial.

Cite

Share

7

Cite

Share

FDG-PET in cervical cancer: staging, re-staging and follow-up.

Bjurberg M, Kjellén E, Ohlsson T, Ridderheim M, Brun E. Bjurberg M, et al. Among authors: ridderheim m. Acta Obstet Gynecol Scand. 2007;86(11):1385-91. doi: 10.1080/00016340701625388. Epub 2007 Sep 4. Acta Obstet Gynecol Scand. 2007. PMID: 17851810 Free article.

Cite

Share

8

Cite

Share

The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.

Malander S, Rambech E, Kristoffersson U, Halvarsson B, Ridderheim M, Borg A, Nilbert M. Malander S, et al. Among authors: ridderheim m. Gynecol Oncol. 2006 May;101(2):238-43. doi: 10.1016/j.ygyno.2005.10.029. Epub 2005 Dec 19. Gynecol Oncol. 2006. PMID: 16360201

Cite

Share

9

Cite

Share

First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.

Lindemann K, Christensen RD, Vergote I, Stuart G, Izquierdo MA, Kærn J, Havsteen H, Eisenhauer E, Ridderheim M, Lopez AB, Hirte H, Aavall-Lundquvist E, Vrdoljak E, Green J, Kristensen GB. Lindemann K, et al. Among authors: ridderheim m. Ann Oncol. 2012 Oct;23(10):2613-2619. doi: 10.1093/annonc/mds060. Epub 2012 Apr 26. Ann Oncol. 2012. PMID: 22539562 Free article. Clinical Trial.

Cite

Share

10

Cite

Share

A single-arm phase II trial of first-line paclitaxel in combination with lapatinib in HER2-overexpressing metastatic breast cancer.

Jagiello-Gruszfeld A, Tjulandin S, Dobrovolskaya N, Manikhas A, Pienkowski T, DeSilvio M, Ridderheim M, Abbey R. Jagiello-Gruszfeld A, et al. Among authors: ridderheim m. Oncology. 2010;79(1-2):129-35. doi: 10.1159/000318043. Epub 2010 Nov 22. Oncology. 2010. PMID: 21088439 Clinical Trial.

Cite

Share